367 related articles for article (PubMed ID: 29630985)
1. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis.
Liu R; Xiao W; Hu C; Xie R; Gao H
J Control Release; 2018 May; 278():127-139. PubMed ID: 29630985
[TBL] [Abstract][Full Text] [Related]
2. Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment.
Liu R; Hu C; Yang Y; Zhang J; Gao H
Acta Pharm Sin B; 2019 Mar; 9(2):410-420. PubMed ID: 30976492
[TBL] [Abstract][Full Text] [Related]
3. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
[TBL] [Abstract][Full Text] [Related]
4. Low-dose paclitaxel via hyaluronan-functionalized bovine serum albumin nanoparticulate assembly for metastatic melanoma treatment.
Chen X; Wang M; Hu Y; Gong T; Zhang ZR; Yu R; Fu Y
J Mater Chem B; 2020 Mar; 8(10):2139-2147. PubMed ID: 32090232
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
[TBL] [Abstract][Full Text] [Related]
7. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
8. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
9. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic Acid Layer-By-Layer (LbL) Nanoparticles for Synergistic Chemo-Phototherapy.
Zhao J; Wan Z; Zhou C; Yang Q; Dong J; Song X; Gong T
Pharm Res; 2018 Aug; 35(10):196. PubMed ID: 30143878
[TBL] [Abstract][Full Text] [Related]
12. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors.
Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289
[TBL] [Abstract][Full Text] [Related]
13. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Wang F; Li L; Liu B; Chen Z; Li C
Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
[TBL] [Abstract][Full Text] [Related]
16. Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis.
Yu W; He X; Yang Z; Yang X; Xiao W; Liu R; Xie R; Qin L; Gao H
Biomaterials; 2019 Oct; 217():119309. PubMed ID: 31271855
[TBL] [Abstract][Full Text] [Related]
17. Size-Transformable Hyaluronan Stacked Self-Assembling Peptide Nanoparticles for Improved Transcellular Tumor Penetration and Photo-Chemo Combination Therapy.
Cong Z; Zhang L; Ma SQ; Lam KS; Yang FF; Liao YH
ACS Nano; 2020 Feb; 14(2):1958-1970. PubMed ID: 32023048
[TBL] [Abstract][Full Text] [Related]
18. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
Cherukula K; Uthaman S; Park IK
Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.
Kim SS; Kim HK; Kim H; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
Arch Pharm Res; 2021 Feb; 44(2):182-193. PubMed ID: 32803685
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
Wu J; Zhang J; Deng C; Meng F; Zhong Z
Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
